Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 3Dermatologic 3Gynecologic 2Genitourinary 2Gastrointestinal 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1CNS 1

Conditions

Pancreatic Neoplasms 16Stomach Neoplasms 14Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 9Ovarian Neoplasms 9Breast Neoplasms 9Neoplasm Metastasis 7Melanoma 7Colonic Neoplasms 7Lung Neoplasms 6Esophageal Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Vaginal Neoplasms 4Small Cell Lung Carcinoma 4Penile Neoplasms 4Oropharyngeal Neoplasms 4Gastrointestinal Neoplasms 4Carcinoma, Renal Cell 4Anus Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Endometrial Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Vulvar Neoplasms 2Urogenital Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Gallbladder Neoplasms 2

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × aldesleukin × Gastrointestinal × Clear all
NCT06690281 2025-09-11

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn
Gastrointestinal

Duodenal Neoplasms, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT02876510 2025-02-04

ACTolog

Immatics US, Inc.

Phase 1 Completed
38 enrolled
GastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡